With about 170 co‑ops and interns in 2025 – roughly 10 per cent of its workforce – Kinaxis Inc. is investing heavily in the ...

Melrose (MLSPF) outlook: 14% revenue growth, strong aerospace aftermarket margins and cash flow upside. Read here for a ...

“For decades, the diabetes world has focused on lowering sugar, not on treating the root cause of the disease nor on stopping its progression” said Dr. Dror Chevion, co-founder and CEO of Concenter ...